Extended nevirapine prophylaxis to prevent HIV transmission

The Lancet

Volumn 372, Issue 9635, 2008, Pages 267-269

  Stringer, Jeffrey SA ^a   Chi, Benjamin H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; DRUG TOLERANCE; HEALTH HAZARD; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LIVER INJURY; MONOTHERAPY; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RASH; TREATMENT DURATION; VIRUS TRANSMISSION;

EID: 47649106085     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61087-9     Document Type: Note

References (9)

1. Breastfeeding and HIV International Transmission Study Group (BHITS). Late postnatal transmission of HIV-1 in breastfed children: an individual patient data meta-analysis. J Infect Dis 189 (2004) 2154-2166
2. Kuhn L., Aldrovandi G., Sinkala M., et al., for the Zambia Exclusive Breastfeeding Study. Effects of early, abrupt weaning for HIV-free survival of children in Zambia. N Engl J Med 359 (2008) 130-141
3. Mbori-Ngacha D., Nduati R., John G., et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA 286 (2001) 2413-2420
4. Six Week Extended-Dose Nevirapine (SWEN) Study Team. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372 (2008) 300-313
5. Kumwenda N., Hoover D., Mofenson L., et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359 (2008) 119-129
6. Taha T., Kumwenda N., Gibbons A., et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 362 (2003) 1171-1177
7. ClinicalTrials.gov. Efficacy and safety of infant peri-exposure prophylaxis with lamivudine to prevent HIV-1 transmission by breastfeeding. May 8, 2008. http://clinicaltrials.gov/ct2/show/NCT00640263 (accessed July 14, 2008).
8. Arrive E., Newell M., Ekouevi D., et al. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 36 (2007) 1009-1021
9. WHO, UNICEF, and UNAIDS. Towards universal access: scaling up prioirity HIV/AIDS interventions in the health sector. Progress report 2008 (June 2, 2008). http://www.who.int/hiv/mediacentre/2008progressreport/en/index.html (accessed July 10, 2008).